I have a colostomy, about 1" opening, and for 8 years I had no problem with my pouches. Then for 3 or 4 months I can't seem to have a bag on for more than a day, and there is leakage. What is deep convexity and should I have different kind of pouches that have a deep convexity? Would that help? Thank you.
Volume 51 - Issue 11 - November, 2005
Protecting Science: A Word Warrior Alert
- 11/1/2005
- 0 Comments
- 2170 reads
U S pharmaceutical companies were not always allowed to advertise directly to consumers. The moment they could, they sought the skills of advertising agencies adept at developing slogans and catchy phrases and applying new words to existing phenomena to increase the appeal of consumer products. Apparently, that strategy worked. Marketing wizardry has helped increase demand for many prescription drugs — especially the new and novel.
Wound, ostomy, and skin care journal readers, as well as some of their patients, see their share of advertisements. Some immediately catch your eye. Other
Letters to the Editor
- 11/1/2005
- 0 Comments
- 1732 reads
Dear Editor,
In the article on the use of Hydrovase (Swiss-American Products, Inc., Dallas, Tex.) (Parnell LKS, Ciufi B, Gokoo CF. Preliminary use of a hydrogel containing enzymes in the treatment of Stage II and Stage III pressure ulcers. Ostomy Wound Manage. 2005;51(8):50-61), the authors noted that the blend of natural enzymes in Hydrovase enhance wound healing, distinguishing them from enzymes used for enzymatic debridement. An ad for Ethezyme (Ethex Corp., Bridgeton, Mo.) that appeared within that article could cause some confusion for your readers because Ethez
Autumnal Announcements
- 11/1/2005
- 0 Comments
- 1817 reads
GAO Evaluates FDA Performance on Medical Device Review Process
The US Food and Drug Administration (FDA) must review all applications for new medical devices. Manufacturers of medical devices have long complained about the arduous and lengthy process they must undergo to bring a new medical device to market. In 2002, Congress passed the Medical Device User Fee and Modernization Act (MDUFMA) that permitted the FDA to collect user fees from manufacturers. Tied to this was a mandate for the FDA to adhere to certain performance goals and timelines in their review process in 20
A Historical Review of Wear Time: Is It Still Relevant?
- 11/1/2005
- 0 Comments
- 4312 reads
“I can only get 3-days’ wear time from my pouching system. What am I doing wrong?”
H ow many times have ostomy specialists heard this complaint? Occasionally, we must step back from what we know is “tried and true” and ask ourselves if what we have been championing for so many years is still relevant. As ostomy pouching systems continue to evolve and improve, is the 7-day wear time gold standard still relevant? Where did it come from? Why do people with an ostomy question themselves and their techniques if they achieve “only” a 2- or 3-day wear time?
Alliance Organizations Address Impact of Support Surface Competitive Bidding with CMS
- 11/1/2005
- 0 Comments
- 2703 reads
A lliance of Wound Care Stakeholders representatives had the opportunity to educate Centers for Medicare and Medicaid Services (CMS) officials on the effect of support surface competitive bidding on physicians, clinicians, manufacturers, providers, and (most importantly) Medicare patients at the Program Advisory and Oversight Committee (PAOC) meeting, September 26–27, 2005, Baltimore, Md. The PAOC was assembled to advise the CMS on crafting a competitive bidding program for durable medical equipment prosthetic and orthotic supplies (DMEPOS), to be implemented in 2007. Currently, the products
New Products/Industry News November 2005
- 11/1/2005
- 0 Comments
- 2863 reads
Health clinic implements new therapy treatment program
Anodyne Therapy™ (Tampa, Fla.) announced that the Cleveland Clinic Health System is implementing use of the Anodyne Therapy System™ in their Home Health Agency, Wound Care Center, and Wooster Podiatry and Physical Therapy Clinics. The Cleveland Clinic Health System has been using the system on an evaluation basis since April 2005 adjunctively with their advanced wound care protocols and physical therapy interventions to significantly increase circulation for wound healing, pain reduction, and balance improvement —
Pass It On: The Power of Mentors
- 11/1/2005
- 0 Comments
- 2071 reads
T he Person Who Changed My Life by Matilda Raffa Cuomo (Barnes & Noble Books; 2002), reminded me of the importance of mentors, advisors, teachers, and coaches in our lives. An educator, a manager, a relative, a random member of your community, church, or synagogue — regardless of title, the influence of that special person has far-reaching effects.
In addition to several family members and acquaintances, my career and nursing mentors have had a profound influence in my life. My undergraduate nursing professor, Desma Reno, RN, MSN, CGN, was an early and profoundly positive inspi
Using a Dermal Skin Substitute in the Treatment of Chronic Wounds Secondary to Recessive Dystrophic Epidermolysis Bullosa: A Cas
- 11/1/2005
- 0 Comments
- 9170 reads
T he term Epidermolysis bullosa (EB) has been used since 1886 to identify a form of hereditary blistering disease and today is commonly used to describe a family of genetic disorders that cause blistering and shearing of the skin from even the mildest trauma.
The disease manifests in several different forms that vary considerably in their severity and symptoms.1 In some forms, the blistering is localized to hands and/or the feet; in others, the whole body can be affected. Blistering also may occur internally (eg, in the mouth or esophagus), giving rise to other complicat
Pain in Acute and Chronic Wounds: A Descriptive Study
- 11/1/2005
- 0 Comments
- 7353 reads
P ain is possibly the most feared sensation in life. In the authors’ opinion, pain disables and distresses more people than any single disease entity and may be the most compelling reason a person seeks healthcare. The significance of pain is neglected in wound care. Internationally, clinicians may ignore patient pain because it is not easy to measure, exhibit biases against pain management, or lack knowledge of available analgesics. Pain is a component of quality of life.1 Patient-centered concerns need to address pain control measures until the cause of the pain can be corrected
Evaluation of a Once-Daily Moisturizer Used to Treat Xerosis in Long-Term Care Patients
- 11/1/2005
- 0 Comments
- 8413 reads
T he body’s largest organ, the skin provides a barrier between an individual and the environment. The skin performs many functions — it protects against infectious micro-organisms, ultraviolet light, noxious substances, and excess fluid/electrolyte loss and provides the means for thermoregulation, sensation, metabolism, and communication.1 The stratum corneum (horny layer) is continuously exposed to the outside environment and provides the first line of protection, serving as a vital part of the body’s immune system.2
Xerosis (dry skin) is characterized by pr
- « Previous
- | Page 1 of 2 |
- Next »
_sm.jpg)
